Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 24 clinical trials
Chemotherapy and G-CSF for Mobilization (MOCCCA)

This study aims to demonstrate that the mobilization with cytokine stimulation with G-CSF alone is non-inferior as compared to the standard mobilization with chemotherapy and G-CSF while associated with fewer side effects in myeloma patients.

melphalan
colony stimulating factor
granulocyte colony stimulating factor
filgrastim
chemotherapy regimen
  • 4 views
  • 26 Feb, 2022
  • 1 location
Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- MBC

This is an open-label, randomized, multicenter Phase 3 study to compare the efficacy and safety of sacituzumab govitecan versus TPC in subjects with metastatic or locally recurrent inoperable HR+/HER2- MBC, after failure of at least 2, and no more than 4, prior chemotherapy regimens for metastatic disease.

  • 7 views
  • 02 May, 2022
  • 39 locations
FUSCC Refractory TNBC Umbrella (FUTURE) (FUTURE)

This is a Phase Ib/II, open-label, multi-center umbrella study evaluating the efficacy and safety of multiple targeted treatment in patients with refractory metastatic TNBC.The specific grouping of patients' depends on FUSCC 500+ gene panel testing and IHC subtype staining.

pyrotinib
parp inhibitor
breast cancer
cancer
vinorelbine
  • 24 views
  • 18 Apr, 2022
  • 1 location
Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy

, Vinorelbine, Ixabepilone, or the control arm (non-microtubule targeted chemotherapies such as doxorubicin, carboplatin, or gemcitabine).

antineoplastic
breast cancer
cancer
vinorelbine
cancer chemotherapy
  • 8 views
  • 28 Feb, 2022
  • 1 location